BONDANZA, ATTILIO
 Distribuzione geografica
Continente #
AS - Asia 4.259
EU - Europa 3.859
NA - Nord America 2.652
SA - Sud America 1.205
AF - Africa 97
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.086
Nazione #
US - Stati Uniti d'America 2.522
RU - Federazione Russa 2.228
SG - Singapore 1.614
CN - Cina 1.277
BR - Brasile 979
SE - Svezia 580
HK - Hong Kong 520
VN - Vietnam 416
IT - Italia 352
FR - Francia 201
DE - Germania 136
AR - Argentina 95
IN - India 89
BD - Bangladesh 84
GB - Regno Unito 84
JP - Giappone 58
CA - Canada 57
EC - Ecuador 48
FI - Finlandia 48
AT - Austria 46
MX - Messico 44
NL - Olanda 39
ZA - Sudafrica 37
IE - Irlanda 35
IQ - Iraq 35
ID - Indonesia 32
CO - Colombia 23
PL - Polonia 23
PY - Paraguay 22
MA - Marocco 19
TR - Turchia 18
UA - Ucraina 16
UZ - Uzbekistan 14
ES - Italia 13
IL - Israele 13
PK - Pakistan 12
SA - Arabia Saudita 12
DZ - Algeria 10
VE - Venezuela 10
CL - Cile 9
TN - Tunisia 9
UY - Uruguay 9
EG - Egitto 8
AU - Australia 7
IR - Iran 7
PE - Perù 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
KE - Kenya 6
LT - Lituania 6
MY - Malesia 6
CH - Svizzera 5
HU - Ungheria 5
KW - Kuwait 5
NZ - Nuova Zelanda 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
JO - Giordania 4
KZ - Kazakistan 4
LV - Lettonia 4
SY - Repubblica araba siriana 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BE - Belgio 3
BH - Bahrain 3
CR - Costa Rica 3
GR - Grecia 3
NP - Nepal 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
RO - Romania 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
KR - Corea 1
Totale 12.077
Città #
Singapore 575
Hong Kong 514
Moscow 513
Dallas 387
San Jose 351
Ashburn 342
Shanghai 251
Hefei 194
Lawrence 185
Princeton 185
Lauterbourg 161
Ho Chi Minh City 145
Beijing 141
New York 132
Milan 100
Hanoi 77
São Paulo 70
Los Angeles 52
Nuremberg 38
Rio de Janeiro 38
Dublin 34
Boardman 29
Santa Clara 28
Orem 27
Helsinki 26
Chennai 23
Guangzhou 23
Tokyo 23
Da Nang 22
Munich 22
Belo Horizonte 21
Johannesburg 21
London 21
Brasília 19
Brooklyn 19
Phoenix 19
Quito 19
Guayaquil 18
Seattle 18
Warsaw 18
Haiphong 17
Vienna 17
Biên Hòa 16
The Dalles 16
Turku 16
Washington 16
Curitiba 15
Montreal 15
Mexico City 13
Boston 12
Campinas 12
Frankfurt am Main 12
Poplar 12
Porto Alegre 12
Rome 12
Tashkent 12
Toronto 12
Baghdad 11
Denver 11
Can Tho 10
Guarulhos 10
Hangzhou 10
Naples 10
Shenzhen 10
Shijiazhuang 10
Ankara 9
Buenos Aires 9
Council Bluffs 9
Hải Dương 9
Salvador 9
Stockholm 9
Xi'an 9
Zhengzhou 9
Amsterdam 8
Fortaleza 8
Goiânia 8
Jiaxing 8
Manchester 8
Montevideo 8
Recife 8
San Francisco 8
Atlanta 7
Chicago 7
Houston 7
Mumbai 7
Reston 7
Santo André 7
Tianjin 7
Volta Redonda 7
Asunción 6
Baku 6
Barnet 6
Bauru 6
Bologna 6
Buffalo 6
Campos dos Goytacazes 6
Caxias do Sul 6
Ciudad del Este 6
Kingston 6
Montes Claros 6
Totale 5.478
Nome #
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 224
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 215
Loss of mismatched HLA in leukemia after stem-cell transplantation 200
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 166
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 163
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 159
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 155
Anti-beta 2 glycoprotein I antibodies cause inflammation and recruit dendritic cells in platelet clearance 141
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 139
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 125
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation 120
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 120
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 116
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 116
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 115
A dual role for genetically modified lymphocytes in cancer immunotherapy 113
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 110
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 107
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 104
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 103
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 99
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 97
Anti-beta 2 glycoprotein I antibodies prevent the de-activation of platelets and sustain their phagocytic clearance 93
An apoptotic cell threshold for dendritic cell maturation and function. 93
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 91
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 91
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 91
Application of Donor Lymphocytes Expressing a Suicide Gene for Early GvL Induction and Later Control of GvH reactions after Bone Marrow Tranaplantation 89
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 88
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 87
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 83
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 83
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 83
Anti-phospholipid antibodies opsonize activated platelets for uptake by dendritic cells: relevance to epitope spreading in platelet autoimmunity. 82
Apoptotic cell-pulsed dendritic cells break tolerance and accelerate lupus in NZB/W F1 mice. 81
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 80
Autoantibody Production during Chronic Graft-Versus-Host Disease Does Not Associate with Long-Term Persistence of Host B Cells in Humans 79
B- and T-cell interactions in graft-versus-host disease 79
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 79
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 78
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 78
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 75
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 75
Stability of human rapamycin-expanded CD4(+)CD25(+) T regulatory cells 74
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 74
TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens 72
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 72
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 72
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 71
The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer 71
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 69
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors 68
Dual Transgenesis of T Cells with a CD44v6 CAR and a Suicide Gene for the Safe Eradication of Myeloid Leukemia and Myeloma 67
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 67
Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4(+) T Cells 67
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 66
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 65
H1N1 vaccination post-allogeneic haematopoietic stem cell transplantation and the risk of GvHD 63
T Cell Receptor Gene Transfer into Early Differentiated Lymphocytes by Lentiviral Vectors for Safe and Effective Adoptive Immune Therapy of Leukemia 63
Use of IL-7 and IL-15 for the genetic modification of memory T lymphocytes 63
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 62
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 62
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 61
Improving the safety of cell therapy with the TK-suicide gene. 61
CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer 61
Jon van Rood (1926-2017) 61
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4(+) and CD8(+) T-cell responses 60
Editing human lymphocytes specificity for safe and effective adoptive immunoterapy of leukemia 60
CD44v6 is associated with chemoresistance induced by bone marrow-derived mesenchymal stromal cells 60
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 60
Clinical pharmacology of CAR-T cells: linking cellular pharmacodynamics to pharmacokinetics and antitumor effects 59
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens 59
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells 59
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation 59
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation 58
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 57
Overcoming the toxicity hurdles of genetically targeted T cells. 57
Requirements for retroviral targeting of a suicide gene to alloreactive memory stem T cells for adoptive immunotherapy of leukemia 57
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 57
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 56
uPA/uPAR system is active in immature dendritic cells derived from CD14(+)CD34(+) precursors and is down-regulated upon maturation 56
Infusion of suicide gene-modified donor T cells promotes a rapid and effective immune reconstitution and provides long-term survival after haploidentical hemaopoietic cell transplantation for the cure of patients with high-risk leukemia 55
Naive-Derived Memory Stem T Cells: A Novel Promising Platform for Cancer Immune-Gene Therapy 55
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 55
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation 55
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies 55
Dual transgenesis of T-cells with a CD44v6 CAR and a suicide gene for the safe eradication of myeloid leukaemia and myeloma 54
Haploidentical HSCT: a 15-year experience at San Raffaele. 54
Immunostimulatory leukemic dendritic cells can efficiently expand leukemia-reactive T cells from HSCT donors 54
Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients 53
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 53
Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors 53
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 53
Modulation of graft-versus-host disease induced by central memory suicide gene modified human T lymphocytes 52
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 52
Harnessing CD1-restricted T cells for the immunotherapy of leukemia 52
Gene transfer of modified idiotype into dendritic cells for immunotherapy of non-Hodgkin lymphomas 52
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 52
Progress and prospects: graft-versus-host disease 51
Use of common gamma-chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes 51
Totale 8.182
Categoria #
all - tutte 82.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022143 0 0 0 68 9 6 10 10 12 16 3 9
2022/20231.094 408 233 67 3 25 119 54 76 62 12 27 8
2023/2024567 26 22 49 52 50 114 59 51 8 30 22 84
2024/20252.647 306 30 34 113 71 186 309 218 477 373 258 272
2025/20267.643 582 626 718 1.231 511 222 604 523 1.993 327 171 135
Totale 12.171